TNK BIOTECH ApS: Financial statements 2025
CVR: 30691911
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
TNK BIOTECH ApS (CVR 30691911) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -11,363 and a net result of DKK -17,528 compared with DKK -15,724 the year before. Equity in the 2025 report amounted to DKK -82,154. The company had 1 employee in the financial year.
- Gross Profit
- DKK -11,363
- Profit/Loss
- DKK -17,528
- Equity
- DKK -82,154
- Total Assets
- DKK 26,853
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -11 t. | -18 t. | -82 t. | 1 |
| 2024 | - | -11 t. | -16 t. | -65 t. | 1 |
| 2023 | - | -9 t. | -11 t. | -49 t. | 1 |
| 2022 | - | -10 t. | -13 t. | -38 t. | 1 |
| 2021 | - | -11 t. | -14 t. | -25 t. | 1 |
Official annual report
How creditworthy is TNK BIOTECH ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
TNK BIOTECH ApS has published its annual report for 2024. Gross profit came to DKK -11,063, and the net result was DKK -15,724.
About TNK BIOTECH ApS
TNK BIOTECH ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2007. The company is registered under the industry Investering for egen regning. The company was previously named TNK INVEST ApS. The management consists of Thomas Nitschke Kledal. The company is owned by Thomas Nitschke Kledal. The company has 0 employees (2013). In 2025, the company reported a gross profit of DKK -11,363 and a net result of DKK -17,528 compared with DKK -15,724 the year before. Equity in the 2025 report amounted to DKK -82,154.